Literature DB >> 6350411

Nifedipine in bronchial asthma.

D Patakas, E Vlachoianni, V Tsara, G Louridas, P Argiropoulou.   

Abstract

In 11 patients with bronchial asthma and regular overnight falls in PEFR of greater than 15%, we demonstrated significant bronchodilation restricted only to large airways after the administration of a single dose of 10 mg of nifedipine. A statistically significant increase in PEFR, SGaw, and FEV1 was noticed at 1 and especially 2 hr after nifedipine administration. During 4 days of nifedipine treatment (10 mg t.i.d.), the overnight fall in mean PEFR was statistically significant (p less than 0.02) and less than the mean fall of PEFR during the 4 days of placebo treatment. Thus nifedipine does modify the basal bronchial tone of patients with asthma and diminishes the circadian swing of airway resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350411     DOI: 10.1016/0091-6749(83)90031-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Efficacy of calcium channel blockers as maintenance therapy for asthma.

Authors:  Mary Ann Twiss; Eloise Harman; Sarah Chesrown; Leslie Hendeles
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium channel blockers and asthma.

Authors:  S Y So; M Ip; W K Lam
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 4.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

Review 5.  Clinical studies with calcium antagonists in asthma.

Authors:  P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Inhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipine.

Authors:  Y Y Kim; S T Holgate; M K Church
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

7.  RWJ-22108--a novel airway tissue--selective calcium channel blocker.

Authors:  J B Moore; W C Miller; S Mockoviak
Journal:  Agents Actions       Date:  1993-09

8.  Inhibition of exercise-induced asthma by nifedipine: a dose-response study.

Authors:  P Rafferty; J G Varley; J S Edwards; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

9.  Inhalation of calcium channel blocking agents protects against methacholine-induced bronchoconstriction.

Authors:  T Tsuda; M Hatta; K Ishikawa; T Nakagawa; N Mabuchi; H Ando; O Nishida
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.